# A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

> **NCT07221591** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 100 (actual)

## Conditions studied

- Healthy

## Interventions

- **COMBINATION_PRODUCT:** survodutide

## Key facts

- **NCT ID:** NCT07221591
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-05
- **Primary completion:** 2026-08-04
- **Final completion:** 2026-08-04
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07221591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07221591, "A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07221591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*